ReachRxResearch
Home
Research
Sign Up
TIF1γ regulates stability of regulatory T cells during inflammation
Back to Research Hub
  1. Home
  2. Research Hub
  3. TIF1γ regulates stability of regulatory…

TIF1γ regulates stability of regulatory T cells during inflammation

Nature Immunology·August 11
ImmunologyPractice changingAutoimmune DiseaseHelminth InfectionInflammationPreclinical Animal Studyβ-Catenin InhibitorAdultTIF1γ

Summary

View source

What was studied

This study examined the role of TIF1γ (Transcriptional Intermediary Factor 1-γ) in maintaining the stability of regulatory T (Treg) cells during inflammation, including autoimmune settings and helminth infection, using TIF1γ-deficient Treg cell models.

Key findings

TIF1γ-deficient Treg cells lost Foxp3 expression and were reprogrammed into pro-inflammatory effector states (Th1-like or Th2-like) in a cell-intrinsic manner; this instability was driven by β-catenin/TCF7 pathway activation rather than disrupted TGFβ signaling. Genetic or pharmacological targeting of β-catenin restored Treg stability and function.

Study limitations

Findings are based on mouse models of Treg-specific TIF1γ deficiency; translation to human Treg biology and clinical relevance is not established. The full paper text provided consists largely of supplementary materials and antibody tables, limiting assessment of full mechanistic detail and statistical rigor.

Clinical implications

TIF1γ-β-catenin signaling is a potential therapeutic target for diseases driven by Treg instability, such as autoimmunity. Pharmacological inhibition of β-catenin may offer a strategy to stabilize Treg identity in inflammatory conditions.

Caveats

  • No human subjects or clinical data are described; all findings are from mouse models. The 'practice_changing' impact flag reflects mechanistic novelty (β-catenin as a Treg stability target) rather than direct clinical evidence.
  • Sample size (total N) could not be determined from the available text; the sample_size tag was omitted.
  • Study design is described as a preclinical mechanistic mouse study; the closest standard label 'Preclinical Animal Study' was applied.
Show all 4
  • The full paper body was not available in the provided text; the abstract was used as the primary data source. Mechanistic details, sample sizes, and statistical outcomes could not be independently verified from the full text.

Related Questions

Explore related topics

What factors control Treg cell stability and Foxp3 expression during inflammation?Can β-catenin inhibitors restore regulatory T cell function in autoimmune disease?How does TGFβ-Smad signaling interact with Treg cell identity and lineage plasticity?

Publication Details

Year
2026
Journal
Nature Immunology
Source
View article
Keep scrolling
More content below.
Up Next